Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice

AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E col...

Full description

Saved in:
Bibliographic Details
Published inActa pharmacologica Sinica Vol. 25; no. 6; pp. 783 - 788
Main Authors Wu, Yong, Chen, Yuan-Zhong, Huang, Hui-Fang, Chen, Ping
Format Journal Article
LanguageEnglish
Published United States 01.06.2004
Subjects
Online AccessGet full text
ISSN1671-4083
1745-7254

Cover

Abstract AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells,and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE, The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure,and DNA fragmentation assay. RESULTS: The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC50 was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GaIN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GaIN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. CONCLUSION: Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.
AbstractList To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.AIMTo study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay.METHODSA cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay.The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice.RESULTSThe expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice.Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.CONCLUSIONRecombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.
To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay. The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.
AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells,and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE, The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure,and DNA fragmentation assay. RESULTS: The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC50 was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GaIN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GaIN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. CONCLUSION: Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.
Author YongWU Yuan-zhongCHEN Hui-fangHUANG PingCHEN
AuthorAffiliation FujianInstituteofHematology,UnionHospital,FujianMedicalUniversity,Fuzhou350001,China
Author_xml – sequence: 1
  givenname: Yong
  surname: Wu
  fullname: Wu, Yong
  organization: Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou 350001, China
– sequence: 2
  givenname: Yuan-Zhong
  surname: Chen
  fullname: Chen, Yuan-Zhong
– sequence: 3
  givenname: Hui-Fang
  surname: Huang
  fullname: Huang, Hui-Fang
– sequence: 4
  givenname: Ping
  surname: Chen
  fullname: Chen, Ping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15169632$$D View this record in MEDLINE/PubMed
BookMark eNo1kNtKxDAQhoOsuAd9BYk33hVyarO5lMUTLAiid0LJYbIbbZPatOD69BZ2hYF_4P_mu5glmsUU4QwtqBRlIVkpZtNeSVoIsuZztMz5kxDOOFUXaE5LWqmKswX6eAWbWhOijgP2wfSTxQ4h4i41hw66ITjAU6d3KYZfyHgPnR6CxV6HZuwBh-hGCw6bA4bo0pB-puNp2mDhEp173WS4OuUKvT_cv22eiu3L4_PmbltYxvlQCO21NIIwCVoKINJrYggjtCLMUu6dkaZcl8yJ0lagqNDOEquUJwwqJhhfodujt-vT9wh5qNuQLTSNjpDGXEuqJCmVmsDrEziaFlzd9aHV_aH-_8cE3BwBu09x9x3irjbafvnQQK3UmjBW8T-FrGuA
ContentType Journal Article
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1745-7254
EndPage 788
ExternalDocumentID 15169632
9980226
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-05
-0E
-Q-
-SE
-S~
.3N
0R~
188
1OC
23M
2RA
2WC
31~
36B
3V.
4.4
53G
5GY
5VR
5VS
6J9
70F
7X7
8-1
88E
8FI
8FJ
8R4
8R5
8RM
92L
92M
9D9
9DE
A8Z
AADWK
AANZL
AAPBV
AAWBL
AAYJO
AAZLF
ABAWZ
ABDEU
ABKZE
ABUWG
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACPRK
ACRQY
ACTTH
ACVWB
ACXQS
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADRAZ
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AEXYK
AFBPY
AFKRA
AFRAH
AFSHS
AFUIB
AFZJQ
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AINHJ
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AOIJS
AXYYD
BAWUL
BBAFP
BBNVY
BENPR
BFHJK
BHPHI
BKKNO
BPHCQ
BVXVI
C1A
CAG
CAJEE
CAJUS
CCEZO
CDYEO
CHBEP
CIEJG
CO8
COF
CQIGP
CS3
CW9
CXBCV
DIK
DNIVK
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FA0
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HH5
HYE
HZI
HZ~
JSO
JUIAU
JZLTJ
K97
KQ8
LH4
LW6
M1P
M48
M7P
MK0
NQJWS
NYICJ
O9-
OK1
OVD
P2P
P6G
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
Q--
Q-4
Q2X
R-E
RNT
RNTTT
RPM
RT5
S..
SNX
SNYQT
SRMVM
SV3
SWTZT
T8U
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
U1F
U1G
U5E
U5O
UKHRP
UMP
UZ5
W91
~88
~NG
~WA
406
AACDK
AASML
AATNV
AAXDM
ABAKF
ABZZP
ACAOD
ACMJI
ACZOJ
AEFQL
AEMSY
AESKC
AEVLU
AFBBN
AGQEE
AIGIU
AJAOE
ALIPV
CCPQU
CGR
CUY
CVF
DPUIP
ECM
EIF
FIGPU
HMCUK
IWAJR
LGEZI
LOTEE
NADUK
NPM
NXXTH
ROL
SOHCF
7X8
SOJ
ID FETCH-LOGICAL-c233t-4afa7b4027ea74e07fa0b0201602c13fdb7b5852d45c6e914adc0c99f02e62423
ISSN 1671-4083
IngestDate Fri Sep 05 13:05:54 EDT 2025
Wed Feb 19 01:40:51 EST 2025
Thu Nov 24 20:31:58 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c233t-4afa7b4027ea74e07fa0b0201602c13fdb7b5852d45c6e914adc0c99f02e62423
Notes R575
31-1347/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15169632
PQID 71970599
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_71970599
pubmed_primary_15169632
chongqing_backfile_9980226
PublicationCentury 2000
PublicationDate 2004-06-01
PublicationDateYYYYMMDD 2004-06-01
PublicationDate_xml – month: 06
  year: 2004
  text: 2004-06-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Acta pharmacologica Sinica
PublicationTitleAlternate Acta Pharmacologica Sinica
PublicationYear 2004
SSID ssj0032319
Score 1.7190052
Snippet AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA...
To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. A cDNA fragment coding for...
To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.AIMTo study the preventive...
SourceID proquest
pubmed
chongqing
SourceType Aggregation Database
Index Database
Publisher
StartPage 783
SubjectTerms Animals
Apoptosis - drug effects
Cell Adhesion
Cells, Cultured
Cricetinae
Endotoxemia - chemically induced
Endotoxemia - pathology
Fibronectins - pharmacology
Galactosamine
Humans
Kidney - cytology
Lipopolysaccharides
Liver - pathology
Liver Failure - chemically induced
Liver Failure - pathology
Male
Mice
Mice, Inbred BALB C
Peptide Fragments - pharmacology
Recombinant Proteins - pharmacology
乙酰半乳糖胺
内毒素
抵抗作用
肝坏死
诱导作用
重组纤维结合蛋白多肽
Title Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice
URI http://lib.cqvip.com/qk/95561A/20046/9980226.html
https://www.ncbi.nlm.nih.gov/pubmed/15169632
https://www.proquest.com/docview/71970599
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZrn_Yydl-6rtXD6EvqYVuKFT-O0RBG1wXmQDYGRpIlGkadrLFh6a_fObJie7RjlxdjFDuxz6d8Pp91LoS8NlIUkhWAgEySgBszDsaJDAONvboF7EmD-c4fLpLpnL9fjBZdtzeXXVKpN_rmzryS_0EVxgBXzJL9B2TbL4UB2Ad8YQsIw_avMEbteKVcLMvQgu5dlUhfJXZeAHkJZFDg4gCuO5XLG7MBr3DtCrRaucRo9CHo8Vo3LqgpQZ6ufixd4OOVD4hry9PqSg7XXZFrAHb4yWVUtpxeOy5f-eegixdoCO1zLcvgy2Xvk2nt31FP62UwkbdPme0ep7u3EbyLmvIEmgjUpE1zmh3DNqnNfib16VL4434pg33xMZ_Mz8_z7GyR7ZE9Frkc7kUbucPAJUVV0_4UlsXA2_gOV_d7oeAchuwheeA9ffq2ge0RuWfKx-Rk1lhxe0qzLvNtc0pP6Kyz7_YJ-drDlvawpT1saQ9b6rGlHlvqsaVqS1tsYZAitk_JfHKWvZsGvhNGoGPGqoBLK4UCqS_gv8VNKKwMFTj6URLGOmK2UEKB7osLPtKJSSMuCx3qNLVhbDABiD0j-yVc5wtCjRpLOyrGBpQyZ0ynIyZTywspY8tTzQfkoDUmeFL6G9YHy0GUg7OXDMjxzro50BCuLcnSrOpNLqJUYKmfAXneGD1fN9VS8ghXYhMWH_zx3JfkfjelDsl-dV2bV-DyVerITYCf7DZimg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recombinant+fibronectin+polypeptide+antagonizes+hepatic+failure+induced+by+endotoxin+in+mice&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Wu%2C+Yong&rft.au=Chen%2C+Yuan-Zhong&rft.au=Huang%2C+Hui-Fang&rft.au=Chen%2C+Ping&rft.date=2004-06-01&rft.issn=1671-4083&rft.volume=25&rft.issue=6&rft.spage=783&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg